These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9828829)
1. Antibody panel in diagnosis of lymphoid neoplasms. Vassallo J; Pinto GA J Clin Pathol; 1998 Aug; 51(8):638-9. PubMed ID: 9828829 [No Abstract] [Full Text] [Related]
2. Antibodies specific for HeLa glycoprotein antigens are also specific for human endocervical epithelium. Mujica van Herckenrode C; Coleman DJ; Stanley M; Koch GL Br J Cancer; 1988 Mar; 57(3):293-4. PubMed ID: 3355768 [No Abstract] [Full Text] [Related]
3. Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry. Clatch RJ; Walloch JL Acta Cytol; 1997; 41(1):109-22. PubMed ID: 9022735 [TBL] [Abstract][Full Text] [Related]
9. Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. Van Laere SJ; Elst H; Peeters D; Benoy I; Vermeulen PB; Dirix LY J Natl Cancer Inst; 2009 Jun; 101(12):895-6; author reply 896-7. PubMed ID: 19509352 [No Abstract] [Full Text] [Related]
10. Preferentially expressed antigen of melanoma (PRAME) in the development of diagnostic and therapeutic methods for hematological malignancies. Matsushita M; Yamazaki R; Ikeda H; Kawakami Y Leuk Lymphoma; 2003 Mar; 44(3):439-44. PubMed ID: 12688312 [TBL] [Abstract][Full Text] [Related]
11. The product of the c-erbB-2 proto-oncogene as a target for diagnosis and therapy in breast cancer. Dean CJ; Allan S; Eccles S; McFarlane C; Styles J; Valeri M; Sandle J; Bakir A; Sacks N Year Immunol; 1993; 7():182-92. PubMed ID: 8103950 [No Abstract] [Full Text] [Related]
12. [Glycolipid markers in tumor cells used in immunologic and immunohistologic diagnosis of tumors. I. Factors affecting the occurrence of glycolipid tumor antigens (review)]. Smíd F Cesk Patol; 1991 Jun; 27(3-4):116-23. PubMed ID: 1913919 [No Abstract] [Full Text] [Related]
13. Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma. Gillett CE; Barnes DM; Camplejohn RS J Clin Pathol; 1993 Dec; 46(12):1126-8. PubMed ID: 7904274 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in tumour diagnosis. Miettinen M Ann Med; 1993 Jun; 25(3):221-33. PubMed ID: 8333922 [TBL] [Abstract][Full Text] [Related]
16. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology. Johansson U; Bloxham D; Couzens S; Jesson J; Morilla R; Erber W; Macey M; Br J Haematol; 2014 May; 165(4):455-88. PubMed ID: 24620735 [No Abstract] [Full Text] [Related]
17. Markers of central nervous system tumors. Birkmayer GD Immunol Ser; 1990; 53():317-22. PubMed ID: 2100565 [No Abstract] [Full Text] [Related]
18. [Biochemical markers of neoplasms of the female genital organs. I. Tissue polypeptide antigen (TPA)]. Kamiński K Ginekol Pol; 1988 Dec; 59(12):739-43. PubMed ID: 3076162 [No Abstract] [Full Text] [Related]
20. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen. Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]